SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-22-000083
Filing Date
2022-06-14
Accepted
2022-06-14 17:16:02
Documents
15
Period of Report
2022-06-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20220610.htm   iXBRL 8-K 45677
2 EX-99.1 ax14jun2022xex991xehadatar.htm EX-99.1 68464
3 EX-99.2 ax14jun2022xex992xtislechi.htm EX-99.2 32676
4 EX-99.3 ax14jun2022xex993xzanucllp.htm EX-99.3 29428
  Complete submission text file 0001651308-22-000083.txt   352365

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20220610.xsd EX-101.SCH 1996
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20220610_lab.xml EX-101.LAB 25214
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20220610_pre.xml EX-101.PRE 13249
9 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20220610_htm.xml XML 11920
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 221015748
SIC: 2834 Pharmaceutical Preparations